IL1B and Alzheimer disease: Moreover, studies have proved that negative regulation of the cell cycle 26, ATP metabolic process 27, cellular respiration 28 and IL1β-mediated signal pathway 29 are involved in AD pathology, which is consistent with our KEGG pathway analysis on the DEGs in AD identified in our study.